SG Americas Securities
LABD icon

SG Americas Securities’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

SG Americas Securities’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-500
Closed -$2.59M – 3318
2018
Q2 		$2.59M Hold
500
– – 0.02% 775
2018
Q1 		$3.65M Buy
500
+82
+20% +$570K 0.03% 557
2017
Q4 		$3.85M Buy
418
+251
+150% +$2.5M 0.04% 502
2017
Q3 		$1.54M Hold
167
– – 0.01% 958
2017
Q2 		$2.3M Buy
167
+150
+882% +$2.88M 0.02% 800
2017
Q1 		$351K Buy
+17
New +$420K ﹤0.01% 2083

Other funds holding LABD

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SG Americas Securities's LABD Position: Q3 2018 in Review

SG Americas Securities sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2018, closing a stake of 500 shares — an estimated $2.59M sold.

SG Americas Securities first reported a position in LABD in Q1 2017 and held it in 6 quarters. The position peaked at $3.85M in Q4 2017. 11 funds tracked by Wall St. Rank hold LABD as of Q3 2018.

  • SG Americas Securities reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2018 after selling out during the quarter.
  • SG Americas Securities sold 500 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2018, an estimated $2.59M.
  • SG Americas Securities first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2017 and held it in 6 quarters.
  • SG Americas Securities's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $3.85M in Q4 2017.
  • 11 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2018.

Based on SG Americas Securities's 13F filing for Q3 2018, filed 6 Nov 2018.